Aptevo Therapeutics Inc.
Ticker: 1671584
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY22 | Q1 FY22 | Q3 FY21 | Q3 FY21 | Q2 FY21 | Q2 FY21 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 3.11+0.0% | 3.11+0.3% | 3.10+0.0% | 3.10-0.3% | 3.11+0.0% | 3.11 |
| Total Income | 3.11+0.0% | 3.11+0.3% | 3.10+0.0% | 3.10-0.3% | 3.11+0.0% | 3.11 |
| EXPENSES | ||||||
| Expenditure | 8.73+0.0% | 8.73+11.2% | 7.85+0.0% | 7.85-11.1% | 8.83+0.0% | 8.83 |
| PROFIT | ||||||
| Net Profit | -7.70+0.0% | -7.70-10.0% | -7.00+0.0% | -7.00+11.7% | -7.93+0.0% | -7.93 |
| KEY METRICS | ||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | — | -1.55-8.4% | -1.43 | — | -1.75 | — |
Corporate Events
Board MeetingAPVO
202622Sep
Board Meeting
Special meeting of stockholders to approve an amendment and …
SEC Filing ↗ Board MeetingAPVO
202621Aug
Board Meeting
Annual Meeting of Stockholders to elect two directors, ratif…
SEC Filing ↗